NASDAQ:ALRN
Delisted

Aileron Therapeutics Stock Signals

etoro logo Buy ALRN
*Your capital is at risk
$2.11
+0 (+0%)
At Close: Apr 09, 2025

Latest Data & Signals Issued

Below are some of the latest signals issued for Aileron Therapeutics Inc

General

Signal Type Signal Value Data
Score 0.000 251 days ( 63.68 %
Last Price $2.11 0 %
Performance History
7 Days
$2.11 $2.11
0%
30 Days
$2.11 $2.11
0%
12 Mos
$5.89 $2.11
-64.18%

5/18

Active Buy Signals

Specific Signals

Short Term
Net score: 54.73
Signal Type Signal Value Importance Data
High / Low N/A Very Low $2.11 - $2.11
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Apr 08, 2025 - 2 days
RSI Short Pivot Signal Sell Very Low Jan 29, 2025 - 50 days
Short MA 3 mos Buy Low Jan 13, 2025 - 61 days
Long MA 3 mos Buy Medium Feb 24, 2025 - 33 days
Short/Long MA 3 mos Buy Medium Feb 24, 2025 - 33 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 25.98
Signal Type Signal Value Importance Data
Trend - 12 mos -33.20 % Very High Width: 1,163.39 %
Pred. range - 12 mos $0.217 - $2.75 High -89.70 % - 30.19 %
Short MA 12 mos Buy Very High Feb 03, 2025 - 47 days
Long MA 12 mos Sell Very High Nov 14, 2024 - 99 days
Short/Long MA 12 mos Sell Very High Dec 05, 2024 - 85 days
Pivot Long Sell Low Apr 08, 2025 - 2 days
RSI Long Pivot Signal Sell Low Feb 07, 2025 - 43 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT AILERON THERAPEUTICS INC
Aileron Therapeutics
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,...
GOLDEN STAR
Ticker Change Signal Date
B
BXDC
$21.71
1.11% Jun 29
SRPT
$17.02
13.28% Jun 29
OSIS
$218.29
1.59% Jun 26
NMRK
$15.02
4.66% Jun 24
JLL
$299.78
9.23% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE